Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

78.77
Delayed Data
As of Aug 31
 -0.57 / -0.72%
Today’s Change
69.90
Today|||52-Week Range
98.95
-8.45%
Year-to-Date
Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth
Aug 31 / GuruFocus News - Paid Partner Content
Novartis (NVS) Reports Positive Phase III Results on MS Drug
Aug 26 / Zacks.com - Paid Partner Content
Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel
Aug 31 / Zacks.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
Aug 26 / Zacks.com - Paid Partner Content
Your Complete Guide to the Generic Drug Industry
Aug 29 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Aug 24 / MotleyFool.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close79.34
Today’s open78.72
Day’s range78.36 - 78.82
Volume1,502,991
Average volume (3 months)1,672,275
Market cap$184.4B
Dividend yield3.45%
Data as of 4:02pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.15%
Revenue growth (last year)-4.75%
P/E ratio28.4
Price/Sales4.25
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.08+0.13%
AGNPRAAllergan plc-5.16-0.62%
PFEPfizer-0.08-0.23%
GSKGlaxoSmithKline+0.10+0.23%
Data as of 4:02pm ET, 08/31/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Search for Jobs